# Objective Markers and New Indicators in AI Disease (OMNI-AID Study)

> **NCT03615859** · — · UNKNOWN · sponsor: **Imperial College London** · enrollment: 100 (estimated)

## Conditions studied

- Adrenal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03615859
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2021-04-02
- **Final completion:** 2021-04-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615859, "Objective Markers and New Indicators in AI Disease (OMNI-AID Study)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03615859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*